DALLAS--(BUSINESS WIRE)--Swiss American CDMO, (Contract Development and Manufacturing Organization), a Dallas-based company that specializes in skin and wound care products, was ranked No. 2039 on the 2019 Inc. 5000 list. The 2019 list recognizes revenue growth from 2015-2018 among US-based, privately held, independent companies. For more than 30 years, Dallas-based Swiss-American has helped build popular brands using a unique blend of marketplace insight, scientific formulation and quality-driven lean manufacturing expertise. Swiss-American was one of three skin care/personal care manufacturers to make the list and the only skin care manufacturer with revenue exceeding $50 million. The company was ranked second out of the 11 Dallas-based manufacturing companies and number six out of 24 Texas-based manufacturing companies named to the prominent list.
"Swiss-American has been in a period of strategic growth over the last several years and we are honored to rank on the Inc. 5000 list this year," said Phil O’Neill, CEO of Swiss-American. “Our team members are seen as innovation drivers in the skin and wound care industries, and this ranking is the result of their efforts.”
Swiss-American’s innovative advances in developing and manufacturing superior topical sun, skin and wound care products for customers around the world, has led to its compound annual growth rate of more than 43% over the past three years. The company’s advanced library of topical formulations, digital/smart/lean manufacturing and strong partnerships have enabled this growth.
Swiss-American has the expertise, infrastructure and equipment to develop and manufacture topical products with prescription, OTC, medical device and personal care/cosmetic market uses. This experience helps ensure clients can better navigate regulatory approvals and address patent/intellectual property issues early in the product development process.
“Our team constantly identifies market and medical needs and creates innovative topical solutions for a variety of disease states, therapeutic areas and global marketplaces,” said Komel Grover, president of Swiss-American. “Our long-standing collaborations with dermatologic thought leaders and academic centers of excellence enable us to generate outcomes that differentiate Swiss-American from our competition, most notably, for sun care, skin care and wound care.”
One of Swiss-American’s most prominent customers is the EltaMD® sunscreen and skincare line, which was acquired from Swiss-American by Colgate-Palmolive® in January 2018. For more than 30 years, Swiss-American staff, dermatology partners and customers worked to develop advanced solutions and improve skin together through the evolution of the successful franchise. In that evolution, EltaMD® has been widely used and became the number one physician-recommended sun care brand. Since the acquisition, Swiss-American has focused on its core expertise of development and manufacturing.
Over the past decade, Swiss-American has been ranked twice as part of Inc. 5000.
About Swiss American CDMO
Swiss American CDMO (Contract Development and Manufacturing Organization) delivers break-through innovation and superior topical manufacturing solutions to global eye, sun, skin and wound care companies for use across the cosmetic, OTC drug and medical device regulatory pathways. For more than 30 years, Dallas-based Swiss-American has helped build popular brands using a unique blend of marketplace insight, scientific formulation and quality-driven lean manufacturing expertise. In 2007, Swiss-American developed and manufactured the widely recognized and physician-recommended, EltaMD® skin and sun care product line, which was divested in 2018 to Colgate-Palmolive. For more information visit www.swissamericancdmo.com.
